Evidence for dermal angiogenesis in breast cancer related lymphedema demonstrated using dual-site fluorescence angiography

Microcirculation. 2002 Jul;9(3):207-19. doi: 10.1038/sj.mn.7800133.

Abstract

Objective: To determine whether the skin expansion associated with breast cancer related lymphedema (BCRL) reduces microvessel density or causes a compensatory angiogenesis.

Methods: Dermal microvessel density was measured by simultaneous fluorescence video angiography in the ipsilateral and contralateral forearms of 25 patients treated for breast cancer, 12 with BCRL (excess volume 30 +/- 20%) and 13 without.

Results: Microvessel density was as high in the swollen arm (27.2 +/- 7.2 mm(-2)) as in the contralateral arm (24.2 +/- 6.2 mm(-2)) despite a 16 +/- 12% increase in local circumference. Total microvessels in a 1-mm annulus of skin was 30% greater in the swollen arm (752 +/- 211) than the contralateral arm (578 +/- 157; p = 0.005, t-test). Microvessel density was similar in each arm in control patients (ipsilateral 24.1 +/- 6.2 mm(-2), contralateral 26.1 +/- 8.8 mm(-2)).

Conclusions: The number of microvessels increased in the expanded skin to maintain microvessel density at a normal level. Therefore, angiogenesis occurs during chronic limb swelling. The control group results indicate that angiogenesis is not caused by the cancer treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arm
  • Blood Pressure
  • Blood Vessels / pathology
  • Body Temperature
  • Breast Neoplasms / complications*
  • Edema / etiology
  • Edema / pathology
  • Female
  • Fluorescein / pharmacokinetics
  • Fluorescein Angiography
  • Fluorescent Dyes / pharmacokinetics
  • Humans
  • Lymphedema / complications*
  • Microcirculation
  • Middle Aged
  • Neovascularization, Pathologic / diagnosis
  • Neovascularization, Pathologic / etiology*
  • Skin / blood supply*
  • Time Factors

Substances

  • Fluorescent Dyes
  • Fluorescein